LONDON, April 15, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Monday, April 14, 2014, with the NASDAQ Composite closing at 4,022.69, up 0.57%, the Dow Jones Industrial Average ending the session at 16173.24, up 0.91%, and the S&P 500 gained 0.82% to finish the trading session at 1830.61. The gains were broad based as all the ten sectors finished on a positive note. A number of stocks saw large movements, including Aruba Networks Inc. (NASDAQ: ARUN), Akebia Therapeutics Inc. (NASDAQ: AKBA), bebe stores inc. (NASDAQ: BEBE) and Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX). Free technical research on ARUN, AKBA, BEBE and MDRX can be downloaded upon signing up at:
On Monday, shares in Aruba Networks Inc. ended the session at $19.98, up 5.94%. A total of 3.09 million shares were traded as compared with its three months average volume of 2.11 million shares. During the session, the stock traded between $19.00 and $20.10. Aruba Networks Inc.'s shares have gained 0.50% in the previous three trading sessions, 0.15% in the last one month and 11.62% on YTD basis. The S&P 500 Information Technology Sector Index mapped a gained of 1.05% during the trading session, while the same has edged lower by 0.46% in the previous three months. Further, the company's stock has a Relative Strength Index (RSI) of 43.53 and is trading above its 200-day moving averages of $18.46. Sign up today to read free research on ARUN at:
Akebia Therapeutics Inc.'s stock closed the day at $21.14, which is 25.39% higher than the previous day's closing price of $16.86. On Monday, the stock oscillated between $17.07 and $23.32 during the trading session with a trading volume of 3.06 million shares. Akebia Therapeutics Inc.'s shares have surged 11.91% in the previous three trading sessions. The S&P 500 Health Care Sector Index mapped a gain of 0.51% during the trading session, while the same has declined 3.97% in the previous one month. Moreover, the company's stock has an RSI of 22.82. Sign up today to read free research on AKBA at:
On Monday, bebe stores inc.'s stock surged 15.15%, finishing the day at $6.69. The stock fluctuated between $6.15 and $6.85 during the session with a trading volume of 1.59 million shares as compared with its three months average volume of 0.37 million shares. Shares in bebe stores inc. have gained 13.20% in the previous three trading sessions, 0.75% in the last one month and 25.75% on YTD basis. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 0.81% during the trading session, but the same has fallen by 3.03% in the last three trading sessions. Furthermore, the company's stock has an RSI of 39.62 and is trading above its 50-day and 200-day moving averages of $5.98 and $5.75, respectively. Sign up today to read free research on BEBE at:
Shares in Allscripts Healthcare Solutions Inc. finished the trading session at $16.57, up 5.01%. A total of 2.98 million shares were traded, which is above their three months average volume of 1.68 million shares. The stock vacillated between $15.78 and $16.77 during the session. Allscripts Healthcare Solutions Inc.'s shares have declined 2.93% in the previous three trading sessions and 13.11% in the last one month, while the stock has advanced 7.18% on YTD basis. The S&P 500 Health Care Sector Index mapped a loss of 1.86% in the previous three months, while the NASDAQ Composite Index declined 3.83% during the same period. Additionally, the company's stock has an RSI of 23.07 and is trading above its 200-day moving average of $15.72. Sign up today to read free research on MDRX at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.